Form 4: Axon Enterprise President Joshua Isner Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Joshua Isner, President of Axon Enterprise, reports acquiring and disposing of common stock related to performance-based restricted stock units.
Summary
- On March 24, 2025, Joshua Isner, President of Axon Enterprise, Inc., reported a transaction involving the acquisition and disposal of common stock.
- The transaction involved the acquisition of 135,822 shares at $0 and the disposal of 317,714 shares.
- These transactions are related to performance-based restricted stock units granted on December 22, 2023, under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.
- The performance conditions for tranches 1 and 2 were certified by the Compensation Committee on the transaction date.
- Tranche 1 will vest on June 2, 2025, and tranche 2 will vest on December 1, 2025, subject to continued employment.
- Vested shares are subject to a minimum holding period until the earlier of December 31, 2030, or the vesting date of a subsequent tranche, excluding shares withheld for taxes.
- Following the reported transactions, Isner beneficially owns 135,822 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions related to executive compensation. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The vesting of the restricted stock units is contingent upon continued employment through June 2, 2025, and December 1, 2025, for tranches 1 and 2, respectively.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Axon Enterprise.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
- The vesting of restricted stock units incentivizes the executive to remain with the company and contribute to its success.
Key Dates
| Date | Description |
|---|---|
| 2023-12-22 | Date of grant for performance-based restricted stock units under the Axon Enterprise, Inc. 2024 eXponential Stock Plan. |
| 2025-03-24 | Date of transaction involving the acquisition and disposal of common stock. |
| 2025-03-26 | Date of signature on the Form 4 filing. |
| 2025-06-02 | Vesting date for tranche 1 of the restricted stock units. |
| 2025-12-01 | Vesting date for tranche 2 of the restricted stock units. |
| 2030-12-31 | End date of the minimum holding period for vested shares (or earlier vesting of a subsequent tranche). |
Keywords
Axon Enterprise, Joshua Isner, Form 4, Beneficial Ownership, Restricted Stock Units, Stock Plan, Common Stock, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.